MedTrace Logo

Gut Microbiota of Preterm Infants and Full-term Infants at Early Life

NCT03373721 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2024-04-17

No results posted yet for this study

Summary

The aim of this study is to obtain a longitudinal view of the gut microbial establishment of a cohort of 51 preterm (PT) infants compared to 50 full-term (FT) infants from birth to 90 days of age, and to identify key clinical factors that affect the establishment of neonatal microbiome.

The hypothesis of the investigators is that the gut microbiota progression of PT group and FT group is different in diversity and composition. Antibiotics and its usage duration is likely the main factor disturbing the colonization and development of the gut microbiome of PT infants.

Conditions

  • Preterm Infant
  • Gut Microbiome

Sponsors & Collaborators

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Jie Jia, PhD · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Eligibility

Min Age
1 Day
Max Age
4 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-20
Primary Completion
2026-11-01
Completion
2028-12-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03373721 on ClinicalTrials.gov